3B BlackBio DX Share Price Today | Stock Price & 3B BlackBio DX Share Screener
As of October 5, 2026, the live 3B BlackBio DX share price (NSE: 3BBLACKBIO) is ₹1,624.70 on NSE and ₹1,630.30 on BSE, down 1.34% from the previous close, with shares trading between ₹1,609.60 and ₹1,734.00 in today's trading session, and a 52-week range of ₹1,102.80–₹1,710.40. Check 3B BlackBio DX 52-week for the annual price range and momentum. Use the 3B BlackBio DX stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today 3B BlackBio DX opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹46 and net income of ₹10, with EBITDA of ₹19, an operating margin of 24.0% and a profit margin of 21.7%.
3B BlackBio DX Share Price Chart
Track the current stock price of 3B BlackBio DX with an interactive chart. Analyse 3BBLACKBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete 3B BlackBio DX stock quote in one place.
The quote of ₹1,624.70 sits between the 52-week low of ₹1,102.80 and the 52-week high of ₹1,710.40, and the latest session moved -1.34% from the previous close.
3B BlackBio DX Company Profile - Fundamental Screener
Screen 3B BlackBio DX company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for 3BBLACKBIO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE994E01018.
Company Details
Classification
Identifiers and Leadership
3B BlackBio DX Balance Sheet Screener
Screen 3BBLACKBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹378, up from ₹296 in 2025.
Latest statistics put total assets at ₹378 and shareholder funds at ₹324.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 378 | 296 | 248 | 214 | 192 | 194 | 45 | 36 | 30 | 26 |
| Current Assets | 193 | 132 | 123 | 114 | 82 | 118 | 39 | 32 | 26 | 22 |
| Fixed Assets | 28 | 7 | 7 | 8 | 7 | 5 | 4 | 4 | 4 | 3 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 10 | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 3 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 324 | 271 | 226 | 196 | 172 | 148 | 34 | 23 | 19 | 11 |
| Share Capital | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 6 | 6 | 6 |
| Reserves & Surplus | 316 | 260 | 215 | 185 | 146 | 125 | 25 | 16 | 12 | 5 |
3B BlackBio DX Income Statement Screener - Profit & Revenue Analysis
Screen 3B BlackBio DX income statement and profit fundamentals. Analyze 3BBLACKBIO quarterly results. 3B BlackBio DX reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹46 and net profit was ₹10, equal to earnings per unit of ₹11.44, at an operating margin of 24%.
In that period expenses were ₹27, interest cost ₹0 and tax ₹5. The next period listed, 2026-Jun, shows revenue of ₹40 and net profit of ₹9.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 46 | 40 | 27 | 27 | 39 | 56 | 27 | 23 | 33 | 28 | 19 | 17 | 22 | 20 | 20 |
| Expenses | 27 | 25 | 15 | 10 | 19 | 29 | 13 | 9 | 13 | 10 | 11 | 8 | 11 | 9 | 13 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 19 | 15 | 13 | 16 | 20 | 27 | 14 | 15 | 20 | 18 | 9 | 9 | 11 | 12 | 8 |
| Operating Profit % | 24.00% | 25.00% | 35.00% | 53.00% | 43.00% | 43.00% | 43.00% | 56.00% | 56.00% | 59.00% | 41.00% | 45.00% | 41.00% | 50.00% | 32.00% |
| Depreciation | 4 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 15 | 13 | 13 | 16 | 20 | 27 | 14 | 14 | 19 | 18 | 8 | 9 | 10 | 11 | 8 |
| Tax | 5 | 4 | 5 | 3 | 5 | 4 | 5 | 3 | 4 | 4 | 3 | 2 | 3 | 3 | 3 |
| Net Profit | 10 | 9 | 8 | 13 | 15 | 22 | 9 | 11 | 15 | 14 | 5 | 7 | 8 | 9 | 5 |
| EPS | 11.44 | 10.48 | 9.38 | 14.76 | 17.55 | 26.19 | 10.26 | 13.19 | 17.35 | 15.75 | 6.94 | 8.41 | 8.86 | 9.94 | 6.43 |
3B BlackBio DX Cash Flow Screener - Liquidity Fundamentals
Screen 3BBLACKBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹43, and net cash flow was an inflow of ₹7.
Over the same period, investing activities used ₹34 and financing activities used ₹3.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 43 | 27 | 20 | 37 | 98 | 7 | 4 | 2 | 1 | 1 |
| Investing Activities | -34 | -20 | 15 | -28 | -70 | -1 | -1 | -1 | 0 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | -3 | -4 | -5 | -15 | -2 | 1 | -1 | 0 | 0 | -1 |
| Net Cash Flow | 7 | 3 | 30 | -6 | 26 | 7 | 2 | 1 | 0 | 0 |
3B BlackBio DX Shareholding Pattern Screener
See 3B BlackBio DX shareholding pattern with promoter, FII, and DII holdings. Check 3B BlackBio DX promoter holding and ownership changes for 3BBLACKBIO on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 40.94%, foreign institutions 2.57%, domestic institutions 1.98% and the public 37.73%, spread across 10,616 shareholders.
The shareholder count was 10,616 in 2026-Mar, compared with 11,049 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 40.94% | 40.95% | 41.28% | 41.28% | 41.28% | 41.28% | 41.29% | 41.29% |
Institutional Investors | ||||||||
| FII Holding | 2.57% | 2.50% | 2.49% | 2.70% | 2.64% | 2.57% | 2.97% | 2.97% |
| DII Holding | 1.98% | 2.15% | 1.60% | 1.76% | 1.82% | 1.88% | 1.89% | 1.89% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 37.73% | 37.05% | 43.31% | 43.17% | 43.53% | 38.09% | 41.94% | 41.94% |
| Other Holding | 16.78% | 17.35% | 11.32% | 11.09% | 10.73% | 16.19% | 11.92% | 11.92% |
| Shareholder Count | 10,616 | 11,049 | 10,345 | 10,619 | 10,709 | 10,507 | 9,753 | 9,753 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by 3B BlackBio DX. 3B BlackBio DX dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹5.00 per unit for 2026-March, a yield of 0.30%, compared with ₹4.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹5.00, ₹4.00 and ₹3.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹5.00 | 0.30% |
| 2025-March | ₹4.00 | 0.36% |
| 2024-March | ₹3.00 | 0.19% |
| 2023-March | ₹2.50 | 0.32% |
| 2022-March | ₹10.50 | 2.62% |
| 2021-March | ₹9.00 | 2.64% |
| 2020-March | ₹0.70 | 0.25% |
| 2019-March | ₹0.50 | 0.69% |
| 2018-March | ₹0.50 | 0.66% |
| 2017-March | ₹0.30 | 0.22% |
3B BlackBio DX Stock Index Membership - Nifty & Sensex
See which indices include 3B BlackBio DX stock. Check 3BBLACKBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
3B BlackBio DX Market Events Screener - Corporate Actions
Get 3B BlackBio DX corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check 3B BlackBio DX stock events that may affect 3BBLACKBIO share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Dividend dated September 22, 2026 and Quarterly Result Announcement dated August 13, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | 6.63% |
| 2026-09-22 | 2026-09-22 | Dividend | ₹ 5.00 /share | 14.87% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 1.02% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -3.06% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -2.84% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 0.77% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | -4.62% |
| 2025-09-19 | 2025-09-19 | Dividend | ₹ 4.00 /share | -29.01% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 3.22% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 15.56% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -6.07% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -3.07% |
| 2024-09-24 | 2024-09-24 | Annual General Meeting | NA | -8.48% |
| 2024-09-17 | 2024-09-18 | Dividend | ₹ 3.00 /share | 79.92% |
| 2023-11-16 | 2023-11-16 | Change Of Name | NA | 0.00% |
3B BlackBio DX Competitors Screener - Peer Stocks Comparison
Screen 3BBLACKBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 33,088 | 61.65 | 2,864 | 12.11% | 510 | 58.65 |
| Vijaya Diagnostic Centre | 14,648 | 78.49 | 835 | 19.34% | 173 | 40.41 |
| Metropolis Healthcare | 11,481 | 55.01 | 1,671 | 24.15% | 191 | 41.27 |
| Thyrocare Technologies | 8,628 | 48.36 | 846 | 20.48% | 163 | 40.76 |
| Nephrocare Health Services | 6,412 | 76.48 | 1,023 | 32.93% | 77 | 30.29 |
| Krsnaa Diagnostics | 1,814 | 18.46 | 816 | 9.90% | 101 | 53.24 |
| Suraksha Diagnostic | 1,728 | 52.04 | 314 | 22.55% | 31 | 48.03 |
| 3B BlackBio DX | 1,394 | 25.24 | 142 | 27.17% | 61 | 63.78 |
| One Global Service Provider | 1,069 | 13.95 | 499 | 237.48% | 70 | 51.70 |
| Health X Platform | 881 | -33.43 | 1,378 | 17.65% | -1 | 34.79 |
3B BlackBio DX Company Announcements - News & Reports Screener
Screen 3BBLACKBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 30, 2026.
The next most recent announcements are dated September 30, 2026 and September 29, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-25 | Closure of Trading Window | - |
| 2026-09-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-09-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-09-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-07 | Letter To Shareholders | - |
| 2026-09-07 | Annual General Meeting To Be Held On 29Th September 2026 | - |
| 2026-09-07 | Dividend Updates | - |
| 2026-09-07 | Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM | - |
| 2026-09-07 | Reg. 34 (1) Annual Report. | - |
| 2026-09-07 | Annual General Meeting To Be Held On 29Th September 2026 | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹1,624.70, within a 52-week range of ₹1,102.80 to ₹1,710.40. The P/E ratio is 25.24 and the P/B ratio is 4.38, with earnings per unit of ₹69.94. Market capitalisation stands at ₹1,394.43 Cr and the dividend yield is 0.30%. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.